<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/xsl" href="http://medicalxpress.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0" 
	xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Medical Xpress: PHYSorg news tagged with: cardiovascular research</title>
<link>http://medicalxpress.com/</link>
<language>en-us</language> 
<description>Medical Xpress internet news portal provides the latest news on Health and Medicine.</description>

 <item>
     <title>Do men's and women's hearts burn fuel differently?</title>
   	 <description>Researchers at the University of Illinois at Chicago College of Medicine will study gender differences in how the heart uses and stores fat—its main energy source—and how changes in fat metabolism play a role in heart disease, under a new $2 million, 4-year grant from the National Heart, Lung and Blood Institute.</description>
     <link>http://medicalxpress.com/news/2013-05-men-women-hearts-fuel-differently.html</link>
	 <category>Medical research</category>
	 <pubDate>Tue, 21 May 2013 08:30:02 EST</pubDate>
	 <guid isPermaLink="false">news288341701</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2013/domensandwom.jpg" width="90" height="90" />
</item>
<item>
     <title>Discovery offers unprecedented look at regulation of gene expression</title>
   	 <description>(Medical Xpress)—A groundbreaking technique developed at the University of Virginia School of Medicine is allowing scientists to examine histone modifications of genetic loci – a process that regulates gene expression – in single cells. The researchers believe the new method will have broad applications for most biomedical areas, most immediately in atherosclerosis research.</description>
     <link>http://medicalxpress.com/news/2013-01-discovery-unprecedented-gene.html</link>
	 <category>Medical research</category>
	 <pubDate>Fri, 25 Jan 2013 06:35:19 EST</pubDate>
	 <guid isPermaLink="false">news278318097</guid>
	 
</item>
<item>
     <title>Steering stem cells to become two different building blocks for new blood vessels</title>
   	 <description>(Medical Xpress)—Growing new blood vessels in the lab is a tough challenge, but a Johns Hopkins engineering team has solved a major stumbling block: how to prod stem cells to become two different types of tissue that are needed to build tiny networks of veins and arteries.</description>
     <link>http://medicalxpress.com/news/2012-12-stem-cells-blocks-blood-vessels.html</link>
	 <category>Cardiology</category>
	 <pubDate>Thu, 20 Dec 2012 15:45:42 EST</pubDate>
	 <guid isPermaLink="false">news275240732</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/steeringstem.jpg" width="90" height="90" />
</item>
<item>
     <title>Research pinpoints key gene for regenerating cells after heart attack</title>
   	 <description>UT Southwestern Medical Center researchers have pinpointed a molecular mechanism needed to unleash the heart's ability to regenerate, a critical step toward developing eventual therapies for damage suffered following a heart attack.</description>
     <link>http://medicalxpress.com/news/2012-12-key-gene-regenerating-cells-heart.html</link>
	 <category>Medical research</category>
	 <pubDate>Thu, 20 Dec 2012 10:37:59 EST</pubDate>
	 <guid isPermaLink="false">news275222211</guid>
	 
</item>
<item>
     <title>Scientists map the genomic blueprint of the heart</title>
   	 <description>Scientists at the Gladstone Institutes have revealed the precise order and timing of hundreds of genetic &quot;switches&quot; required to construct a fully functional heart from embryonic heart cells—providing new clues into the genetic basis for some forms of congenital heart disease.</description>
     <link>http://medicalxpress.com/news/2012-09-scientists-genomic-blueprint-heart.html</link>
	 <category>Medical research</category>
	 <pubDate>Thu, 13 Sep 2012 12:46:15 EST</pubDate>
	 <guid isPermaLink="false">news266759167</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/9-scientistsma.jpg" width="90" height="90" />
</item>
<item>
     <title>Promising new drug target discovered for treatment and prevention of heart failure</title>
   	 <description>A promising new drug target for the treatment and prevention of heart failure has been discovered by researchers at Mount Sinai School of Medicine in New York, NY, US. The study was presented at the ESC Congress 2012 by principal investigator Professor Roger J. Hajjar, MD.</description>
     <link>http://medicalxpress.com/news/2012-08-drug-treatment-heart-failure.html</link>
	 <category>Cardiology</category>
	 <pubDate>Mon, 27 Aug 2012 11:00:02 EST</pubDate>
	 <guid isPermaLink="false">news265280484</guid>
	 
</item>
<item>
     <title>Death risks higher for heart attack survivors living near major roadways: research</title>
   	 <description>Heart attack survivors who live about 100 meters (328 feet) or less from a major U.S. roadway face increased risk of death from all causes, according to new research in the American Heart Association's journal Circulation.</description>
     <link>http://medicalxpress.com/news/2012-05-death-higher-heart-survivors-major.html</link>
	 <category>Cardiology</category>
	 <pubDate>Mon, 07 May 2012 16:00:10 EST</pubDate>
	 <guid isPermaLink="false">news255606108</guid>
	 
</item>
<item>
     <title>Immune therapies: The next frontier in battle against atherosclerosis</title>
   	 <description>New strategies injecting cardiovascular disease (CVD) patients with vaccines and monoclonal antibodies to combat atherosclerosis could soon change the treatment landscape of heart disease. Both approaches, Professor Jan Nilsson told delegates at the Frontiers in CardioVascular Biology (FCVB) 2012 meeting, can be considered truly ground breaking since for the first time they target the underlying cause of CVD. The FCVB meeting, organised by the Council on Basic Cardiovascular Science (CBCS) of the European Society of Cardiology (ESC), held 30 March to 1 April at the South Kensington Campus of Imperial College in London.</description>
     <link>http://medicalxpress.com/news/2012-03-immune-therapies-frontier-atherosclerosis.html</link>
	 <category>Cardiology</category>
	 <pubDate>Fri, 30 Mar 2012 09:47:23 EST</pubDate>
	 <guid isPermaLink="false">news252319633</guid>
	 
</item>
<item>
     <title>Stand up: Study provides new evidence on the harms of prolonged sitting</title>
   	 <description>Standing up more often may reduce your chances of dying within three years, even if you are already physically active, a study of more than 200,000 people published in Archives of Internal Medicine today shows.</description>
     <link>http://medicalxpress.com/news/2012-03-evidence-prolonged.html</link>
	 <category>Health</category>
	 <pubDate>Mon, 26 Mar 2012 16:00:10 EST</pubDate>
	 <guid isPermaLink="false">news251984133</guid>
	 
</item>
<item>
     <title>Researchers discover first-ever link between tiny genetic structures, imminent heart attack risk</title>
   	 <description>Researchers at the Intermountain Medical Center Heart Institute have, for the first time ever, made a connection between tiny genetic molecules called microRNAs and the imminent threat of a heart attack, according to a new study.</description>
     <link>http://medicalxpress.com/news/2012-03-first-ever-link-tiny-genetic-imminent.html</link>
	 <category>Cardiology</category>
	 <pubDate>Sun, 25 Mar 2012 15:30:01 EST</pubDate>
	 <guid isPermaLink="false">news251904285</guid>
	 
</item>
<item>
     <title>Protein discovery could switch off cardiovascular disease</title>
   	 <description>Researchers from Queen Mary, University of London and the University of Surrey have found a protein inside blood vessels with an ability to protect the body from substances which cause cardiovascular disease.</description>
     <link>http://medicalxpress.com/news/2012-03-protein-discovery-cardiovascular-disease.html</link>
	 <category>Cardiology</category>
	 <pubDate>Sun, 11 Mar 2012 19:00:01 EST</pubDate>
	 <guid isPermaLink="false">news250687373</guid>
	 
</item>
<item>
     <title>Heart patients who take vitamins less likely to take medication as prescribed, according to study</title>
   	 <description>Atrial Fibrillation patients who are prescribed the powerful blood thinner warfarin often take it with vitamins or supplements that can hamper its effectiveness, or skip doses completely, increasing their risk for stroke, according to new research.</description>
     <link>http://medicalxpress.com/news/2011-11-heart-patients-vitamins-medication.html</link>
	 <category>Cardiology</category>
	 <pubDate>Mon, 14 Nov 2011 17:33:08 EST</pubDate>
	 <guid isPermaLink="false">news240514381</guid>
	 
</item>
<item>
     <title>High testosterone levels and lower heart risks tied together</title>
   	 <description>(Medical Xpress) -- A new study published in the Journal of the American College of Cardiology reports that higher natural levels of testosterone in elderly men may reduce their risk of a heart attack or stroke.</description>
     <link>http://medicalxpress.com/news/2011-10-high-testosterone-heart-tied.html</link>
	 <category>Cardiology</category>
	 <pubDate>Thu, 06 Oct 2011 11:41:06 EST</pubDate>
	 <guid isPermaLink="false">news237120048</guid>
	 
</item>
<item>
     <title>Computers find EKG anomalies, warn whose heart attacks could be fatal</title>
   	 <description>Newly discovered subtle markers of heart damage hidden in plain sight among hours of EKG recordings could help doctors identify which heart attack patients are at high risk of dying soon.</description>
     <link>http://medicalxpress.com/news/2011-09-ekg-anomalies-heart-fatal.html</link>
	 <category>Cardiology</category>
	 <pubDate>Wed, 28 Sep 2011 14:00:06 EST</pubDate>
	 <guid isPermaLink="false">news236432792</guid>
	 
</item>
<item>
     <title>Promising target in treating and preventing the progression of heart failure identified</title>
   	 <description>Researchers at Mount Sinai School of Medicine have identified a new drug target that may treat and/or prevent heart failure. The team evaluated failing human and pig hearts and discovered that SUMO1, a so-called &quot;chaperone&quot; protein that regulates the activity of key transporter genes, was decreased in failing hearts. When the researchers injected SUMO1 into these hearts via gene therapy, cardiac function was significantly improved. This research indicates that SUMO1 may play a critical role in the pathogenesis of heart failure. The data are published online in Nature.</description>
     <link>http://medicalxpress.com/news/2011-09-heart-failure.html</link>
	 <category>Cardiology</category>
	 <pubDate>Wed, 07 Sep 2011 13:00:10 EST</pubDate>
	 <guid isPermaLink="false">news234618984</guid>
	 
</item>
<item>
     <title>Scientist discovers genetic factor implicated in heartbeat defect</title>
   	 <description>A scientist at the Gladstone Institutes has discovered how gene regulation can make hearts beat out of sync, offering new hope for the millions who suffer from a potentially fatal heart condition.</description>
     <link>http://medicalxpress.com/news/2011-08-scientist-genetic-factor-implicated-heartbeat.html</link>
	 <category>Medical research</category>
	 <pubDate>Mon, 08 Aug 2011 15:20:01 EST</pubDate>
	 <guid isPermaLink="false">news232035365</guid>
	 
</item>
<item>
     <title>Gene therapy delivered once to blood vessel wall protects against atherosclerosis in rabbit studies</title>
   	 <description>A one-dose method for delivering gene therapy into an arterial wall effectively protects the artery from developing atherosclerosis despite ongoing high blood cholesterol. The promising results, published July 19 in the journal Molecular Therapy, came from research in rabbits.</description>
     <link>http://medicalxpress.com/news/2011-07-gene-therapy-blood-vessel-wall.html</link>
	 <category>Medical research</category>
	 <pubDate>Tue, 19 Jul 2011 15:23:38 EST</pubDate>
	 <guid isPermaLink="false">news230307799</guid>
	 
</item>


</channel>
</rss>
